Preliminary screenings by our group on mesenchymal tumors revealed CYP2W1 overexpression in a small subset of rhabdomyosarcomas, the most common pediatric STS subtype [20]. This evidence concerns the gene CYP2W1 and rhabdomyosarcoma.